{"id":"https://openalex.org/W2945979059","doi":null,"title":"Adding Ribociclib Improves PFS in Advanced, HR-Positive Breast Cancer","display_name":"Adding Ribociclib Improves PFS in Advanced, HR-Positive Breast Cancer","publication_year":2016,"publication_date":"2016-10-10","ids":{"openalex":"https://openalex.org/W2945979059","mag":"2945979059"},"language":"en","primary_location":{"id":"mag:2945979059","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/breast-cancer/adding-ribociclib-improves-pfs-advanced-hr-positive-breast-cancer","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012027631","display_name":"Dave Levitan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Dave Levitan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5012027631"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34305677,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":1.0},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.7360000014305115},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.8970000147819519},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9300000071525574},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.9259999990463257},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.597943127155304},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47470206022262573},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43557208776474},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4137563407421112},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38050466775894165}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2945979059","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/breast-cancer/adding-ribociclib-improves-pfs-advanced-hr-positive-breast-cancer","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2530535713","https://openalex.org/W2553837762","https://openalex.org/W2943730803","https://openalex.org/W2936036393","https://openalex.org/W4223442080","https://openalex.org/W4250707374","https://openalex.org/W4249750569","https://openalex.org/W2528767298","https://openalex.org/W2763885557","https://openalex.org/W4220709633"],"abstract_inverted_index":{"Adding":[0],"ribociclib,":[1],"a":[2],"CDK4/6":[3],"inhibitor,":[4],"to":[5],"letrozole":[6],"significantly":[7],"improved":[8],"progression-free":[9],"survival":[10],"in":[11],"postmenopausal":[12],"women":[13],"with":[14],"advanced,":[15],"HR-positive/HER2-negative":[16],"breast":[17],"cancer.":[18]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2019-05-29T00:00:00"}